Comparison of detection methods for cell surface globotriaosylceramide.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  JIM - Journal of Immunological Methods

• Publication date

  2011-08-31

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jim.2011.06.014PMID 21726561
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cholesterol modulates glycolipid conformation and receptor activity.

  2011cited by this paper
• A synthetic globotriaosylceramide analogue inhibits HIV-1 infection in vitro by two mechanisms

  2010cited by this paper
• Shiga toxins — from cell biology to biomedical applications

  2010cited by this paper
• Shiga toxin and its use in targeted cancer therapy and imaging

  2010cited by this paper
• Globotriaosyl ceramide receptor function – Where membrane structure and pathology intersect

  2010cited by this paper
• A Major Fraction of Glycosphingolipids in Model and Cellular Cholesterol-containing Membranes Is Undetectable by Their Binding Proteins*

  2010cited by this paper
• Human Intestinal Tissue and Cultured Colonic Cells Contain Globotriaosylceramide Synthase mRNA and the Alternate Shiga Toxin Receptor Globotetraosylceramide

  2010cited by this paper
• The function of rhamnose-binding lectin in innate immunity by restricted binding to Gb3.

  2009cited by this paper
• Expression of verotoxin-1 receptor Gb3 in breast cancer tissue and verotoxin-1 signal transduction to apoptosis

  2009cited by this paper
• Detergent-resistant globotriaosyl ceramide may define verotoxin/glomeruli-restricted hemolytic uremic syndrome pathology.

  2009cited by this paper
• The human P(k) histo-blood group antigen provides protection against HIV-1 infection.

  2009cited by this paper
• Human colorectal tumors and metastases express Gb3 and can be targeted by an intestinal pathogen-based delivery tool

  2008cited by this paper
• Induction of HIV-1 resistance: cell susceptibility to infection is an inverse function of globotriaosyl ceramide levels.

  2008cited by this paper
• Lipid rafts: contentious only from simplistic standpoints

  2006cited by this paper
• A novel soluble mimic of the glycolipid, globotriaosyl ceramide inhibits HIV infection

  2006cited by this paper
• Treatment of neutral glycosphingolipid lysosomal storage diseases via inhibition of the ABC drug transporter, MDR1

  2006cited by this paper
• Targeted Disruption of Gb3/CD77 Synthase Gene Resulted in the Complete Deletion of Globo-series Glycosphingolipids and Loss of Sensitivity to Verotoxins*

  2006cited by this paper
• A comparison of Verotoxin B-subunit (Stx1B) and CD77 antibody to define germinal centre populations.

  2005cited by this paper
• Pharmacokinetic interactions between efavirenz and rifampicin in the treatment of HIV and tuberculosis: one size does not fit all

  2005cited by this paper
• Expression of Neutral Glycosphingolipids in Cytokine-Stimulated Human Endothelial Cells

  2004cited by this paper
• Differential carbohydrate epitope recognition of globotriaosyl ceramide by verotoxins and a monoclonal antibody.

  2004cited by this paper
• Two Distinct Gb3/CD77 Signaling Pathways Leading to Apoptosis Are Triggered by Anti-Gb3/CD77 mAb and Verotoxin-1*

  2003cited by this paper
• The role of glycosphingolipids in HIV signaling, entry and pathogenesis

  2003cited by this paper
• Expression of the Gb3/CD77 Synthase Gene in Megakaryoblastic Leukemia Cells

  2002cited by this paper
• Molecular basis for high renal cell sensitivity to the cytotoxic effects of shigatoxin-1: upregulation of globotriaosylceramide expression.

  2002cited by this paper
• The treatment of malignant meningioma with verotoxin.

  2002cited by this paper
• Apoptosis of Renal Tubular Cells in Shiga-Toxin-Mediated Hemolytic Uremic Syndrome

  2001cited by this paper
• Comparison of adhesion mechanisms and surface protein expression in CD77-positive and CD77-negative Burkitt's lymphoma cells.

  2001cited by this paper
• MHC class II proteins contain a potential binding site for the verotoxin receptor glycolipid CD77.

  2001cited by this paper
• Role of lipid rafts in Shiga toxin 1 interaction with the apical surface of Caco-2 cells.

  2001cited by this paper
• Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes.

  2001cited by this paper
• Localization of the Binding Site for the Oligosaccharide Moiety of Gb3 on Verotoxin 1 Using NMR Residual Dipolar Coupling Measurements

  2000cited by this paper
• Functional significance of globotriaosyl ceramide in interferon‐α2/type 1 interferon receptor‐mediated antiviral activity

  2000cited by this paper
• Apparent cooperativity in multivalent verotoxin-globotriaosyl ceramide binding: kinetic and saturation binding studies with [(125)I]verotoxin.

  2000cited by this paper
• Targeted toxins.

  2000cited by this paper
• Localization of the binding site for the oligosaccharide moiety of Gb3 on verotoxin 1 using NMR residual dipolar coupling measurements.

  2000cited by this paper
• Globotriaosyl ceramide (CD77/Gb3) in the glycolipid-enriched membrane domain participates in B-cell receptor-mediated apoptosis by regulating lyn kinase activity in human B cells.

  2000cited by this paper
• The identification of three biologically relevant globotriaosyl ceramide receptor binding sites on the Verotoxin 1 B subunit

  1999cited by this paper
• Globotriaosyl ceramide modulates interferon-α-induced growth inhibition and CD19 expression in Burkitt's lymphoma cells

  1999cited by this paper
• Activation of Src Family Kinase Yes Induced by Shiga Toxin Binding to Globotriaosyl Ceramide (Gb3/CD77) in Low Density, Detergent-insoluble Microdomains*

  1999cited by this paper
• Verotoxin induces apoptosis and the complete, rapid, long-term elimination of human astrocytoma xenografts in nude mice.

  1999cited by this paper
• Role of Glycosphingolipids in HIV-1 Entry: Requirement of Globotriosylceramide (Gb3) in CD4/CXCR4-dependent Fusion

  1999cited by this paper
• Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3.

  1998cited by this paper
• HIV-1-induced perturbations of glycosphingolipid metabolism are cell-specific and can be detected at early stages of HIV-1 infection.

  1998cited by this paper
• Verotoxins induce apoptosis in human renal tubular epithelium derived cells.

  1998cited by this paper
• The neutral glycosphingolipid globotriaosylceramide promotes fusion mediated by a CD4-dependent CXCR4-utilizing HIV type 1 envelope glycoprotein.

  1998cited by this paper
• Gal alpha 4Gal-binding antibodies: specificity and use for the mapping of glycolipids of Burkitt lymphoma and other human tumors.

  1996cited by this paper
• Influence of phospholipid chain length on verotoxin/globotriaosyl ceramide binding in model membranes: comparison of a supported bilayer film and liposomes

  1996cited by this paper
• Role of verotoxin receptors in pathogenesis.

  1996cited by this paper
• The P blood group system: biochemical, serological, and clinical aspects.

  1995cited by this paper
• pp60c-src expression is induced by activation of normal human T lymphocytes.

  1995cited by this paper
• Capping and receptor‐mediated endocytosis of cell‐bound verotoxin (shiga‐like toxin) 1: Chemical identification of an amino acid in the B subunit necessary for efficient receptor glycolipid binding and cellular internalization

  1994cited by this paper
• Glycoproteins with Gal alpha 4Gal are absent from human erythrocyte membranes, indicating that glycolipids are the sole carriers of blood group P activities.

  1994cited by this paper
• Evidence that verotoxins (Shiga-like toxins) from Escherichia coli bind to P blood group antigens of human erythrocytes in vitro

  1994cited by this paper
• Lipid modulation of glycolipid receptor function. Availability of Gal(alpha 1-4)Gal disaccharide for verotoxin binding in natural and synthetic glycolipids.

  1994cited by this paper
• Lipid modulation of glycolipid receptor function

  1994cited by this paper
• Endothelial heterogeneity in Shiga toxin receptors and responses.

  1993cited by this paper
• Alteration of the carbohydrate binding specificity of verotoxins from Gal alpha 1-4Gal to GalNAc beta 1-3Gal alpha 1-4Gal and vice versa by site-directed mutagenesis of the binding subunit.

  1992cited by this paper
• Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum

  1992cited by this paper
• Serological responses to the B subunit of Shiga-like toxin 1 and its peptide fragments indicate that the B subunit is a vaccine candidate to counter action of the toxin

  1991cited by this paper
• Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function.

  1991cited by this paper
• Characterization of Shiga-like toxin I B subunit purified from overproducing clones of the SLT-I B cistron.

  1990cited by this paper
• Neutral glycosphingolipids of the globo-series characterize activation stages corresponding to germinal center B cells.

  1990cited by this paper
• Expression of glycolipid receptors to Shiga-like toxin on human B lymphocytes: a mechanism for the failure of long-lived antibody response to dysenteric disease.

  1990cited by this paper
• Changes in glycolipid expression in human testicular tumor

  1990cited by this paper
• Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2.

  1988cited by this paper
• Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro.

  1987cited by this paper
• Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype.

  1987cited by this paper
• Subpopulations of B lymphocytes in germinal centers.

  1987cited by this paper
• Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1.

  1987cited by this paper
• Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin- binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide

  1986cited by this paper
• The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

  1985cited by this paper
• Expression of burkitt lymphoma‐associated antigen (defined by the monoclonal antibody 38.13) on both normal and malignant germinal‐centre B cells

  1985cited by this paper
• The P blood group system: recent progress in immunochemistry and genetics.

  1981cited by this paper
• Monoclonal antibody against a Burkitt lymphoma-associated antigen.

  1981cited by this paper
• Human erythrocyte P and Pk blood group antigens: identification as glycosphingolipids.

  1974cited by this paper
• A simple method for the isolation and purification of total lipides from animal tissues.

  1957cited by this paper

• Repurposing the Pentameric B-subunit of Shiga Toxin for Gb3-targeted Immunotherapy of Colorectal Cancer by Rhamnose Conjugation.

  2022cites this paper
• Cell Biological Responses after Shiga Toxin-1 Exposure to Primary Human Glomerular Microvascular Endothelial Cells from Pediatric and Adult Origin

  2021cites this paper
• Therapeutic Uses of Bacterial Subunit Toxins

  2021cites this paper
• Primary Human Derived Blood Outgrowth Endothelial Cells: An Appropriate In Vitro Model to Study Shiga Toxin Mediated Damage of Endothelial Cells

  2020influential citation
• Kinase Inhibitors and Nucleoside Analogues as Novel Therapies to Inhibit HIV-1 or ZEBOV Replication

  2017cites this paper
• Lipid requirements for entry of protein toxins into cells.

  2014cites this paper
• c-Src and Pyk2 Protein Tyrosine Kinases Play Protective Roles in Early HIV-1 Infection of CD4+ T-Cell Lines

  2014cites this paper
• CD4+ T-cells are unable to express the HIV natural resistance factor globotriosylceramide

  2013influential citation
• Association of Shiga toxin glycosphingolipid receptors with membrane microdomains of toxin-sensitive lymphoid and myeloid cells[S]

  2013cites this paper
• Cholesterol masks membrane glycosphingolipid tumor-associated antigens to reduce their immunodetection in human cancer biopsies.

  2013cites this paper
• Involvement of l(–)-rhamnose in sea urchin gastrulation: a live embryo assay

  2013cites this paper
• Electrochemical characterization of globotriose-containing self-assembled monolayers on nanoporous gold and their binding of soybean agglutinin.

  2013cites this paper
• Nanoporous Gold as a Solid Support for Protein Immobilization for the Development of Immunoassays, and for Biomolecular Interaction Studies

  2012cites this paper
• Glycosphingolipids in HIV/AIDS: The Potential Therapeutic Application

  2011cites this paper